Dermatology Research and Practice · 2020 · 13 citations · 24 references
MedicineDermatologyPathologyDermatopathologyHistopathologyImmunopathologyAutoimmune Skin DiseasesImmunopathology Of SkinInflammatory DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersBullous DermatosesDisease Severity EstimationImmunofluorescence DiagnosisImmunofluorescence FindingsImmunofluorescence StainingMale-to-female RatioOral Cavity LesionsOral Cavity Pathology
Background . Pemphigus vulgaris is a rare bullous autoimmune dermatosis whose evolution and prognosis are unpredictable. Aim . The objective was to analyze long-term outcomes in patients with pemphigus vulgaris by identifying the factors that are able to influence prognosis, in particular the phenotype of pemphigus vulgaris, age at onset, multiplicity of mucosal involvement, relapse and remission rates, and survival functions. Methods . A retrospective analysis of a cohort of 31 patients followed for pemphigus vulgaris during the period from January 2004 to January 2014. Inclusion criteria were a diagnosis of pemphigus vulgaris confirmed by histopathology and direct immunofluorescence (DIF) and a period of follow-up of at least five years from the diagnosis. The following information was collected by a single investigator. Results . In total, 67.7% of patients presented a mucocutaneous pemphigus vulgaris. Male-female sex ratio was 2.4. The median duration of patient’s follow-up was estimated at 7 (6–9) years. Multiple mucosal involvement in the oral cavity and at other mucosal sites was significantly associated with severe mucocutaneous pemphigus vulgaris (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:math>). Multiple relapses were significantly associated with the disease severity (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.04</mml:mn></mml:math>). Conclusion . Poor prognosis factors were severe mucocutaneous type of pemphigus vulgaris and multiple mucosal involvement in the oral cavity and at other mucosal sites.
24
The Adjuvant Therapy of Pemphigus
J C Bystryn · Archives of Dermatology · 1996 · 303 citations
Pemphigus: Analysis of 1209 cases
Cheyda Chams‐Davatchi, Mahin Valikhani, Maryam Daneshpazhooh et al. · International Journal of Dermatology · 2005 · 256 citations
Medicine, Dermatology, Pathology +5